Omada Health President Wei-Li Shao Sells 9,418 Shares for $236,000

Jack Delaney, The Motley Fool

Wed, September 23, 2026 at 5:50 AM PDT 4 min read

Wei-Li Shao, President of Omada Health (NASDAQ:OMDA), sold 9,418 shares of the company on Aug. 12, 2026, according to a recent SEC Form 4 filing.

Transaction summary

Transaction value based on SEC Form 4 weighted average sale price ($25.02); post-transaction value based on Aug. 12, 2026, market close ($23.84).

Key questions

• What governed the timing of this executive sale?
  The transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the president on March 13, 2026. These plans allow insiders to establish a pre-determined schedule for selling stock to avoid concerns regarding material non-public information.

• How does this disposal affect the insider's total equity exposure?
  The president continues to hold over 307,000 shares directly after the transaction. As of the Sept. 4, 2026, market close, this remaining direct position was valued at approximately $7 million based on a stock price of $22.77.

• What was the performance context of the stock at the time of the sale?
  As of the Aug. 12, 2026, transaction date, Omada Health shares had appreciated by 24% over the preceding 12-month period.

• What is the company's current scale of operations and financial standing?
  Omada Health provides virtual care programs, including cardiometabolic support for prediabetes and hypertension. The company reported trailing-twelve-month revenue of $309.8 million and net income of $4.3 million, supported by a staff of 946 employees.

Company Overview

Company Snapshot

• Omada Health delivers comprehensive virtual care programs focused on cardiometabolic conditions, including prediabetes, diabetes, and hypertension, as well as physical therapy services for musculoskeletal conditions and behavioral health support programs.

• The company generates revenue through employer-sponsored and payer-based virtual care delivery models, providing digital health solutions that address chronic disease management and preventive care across its platform.

• Omada's primary customers include health plans, employers, and healthcare systems seeking to reduce healthcare costs and improve clinical outcomes for members with chronic conditions.

Omada Health operates as a leading digital health platform with approximately 946 employees and a market capitalization of $1.3 billion. The company has demonstrated strong growth momentum, with TTM revenue of $309.80 million and a 35.4% stock price appreciation thus far in 2026, reflecting investor confidence in its virtual care delivery model. Omada's competitive positioning is anchored in its integrated suite of evidence-based programs and proprietary technology platform designed to engage patients and drive measurable health outcomes across multiple chronic disease categories.